
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Prognostic implications of EBER and EBV DNA combinations in nasopharyngeal carcinoma in endemic areas - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4B7BC8AF3DF7305B7BC004132EEA4.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="bmcorhl">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374416/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="BMC Oral Health">
<meta name="citation_title" content="Prognostic implications of EBER and EBV DNA combinations in nasopharyngeal carcinoma in endemic areas">
<meta name="citation_author" content="Ying Li">
<meta name="citation_author_institution" content="Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014 China">
<meta name="citation_author" content="Lishui Wu">
<meta name="citation_author_institution" content="Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014 China">
<meta name="citation_author" content="Zongwei Huang">
<meta name="citation_author_institution" content="Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014 China">
<meta name="citation_author" content="Sunqiu Cai">
<meta name="citation_author_institution" content="Department of Radiation Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000 Fujian China">
<meta name="citation_author" content="Siqi Xu">
<meta name="citation_author_institution" content="Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014 China">
<meta name="citation_author" content="Jue Wang">
<meta name="citation_author_institution" content="Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014 China">
<meta name="citation_author" content="Yuxin Yu">
<meta name="citation_author_institution" content="Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014 China">
<meta name="citation_author" content="Jinghua Lai">
<meta name="citation_author_institution" content="Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014 China">
<meta name="citation_author" content="Dan Hu">
<meta name="citation_author_institution" content="Department of Pathology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014 China">
<meta name="citation_author" content="Sufang Qiu">
<meta name="citation_author_institution" content="Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014 China">
<meta name="citation_author_institution" content="Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, 350014 Fujian China">
<meta name="citation_author_institution" content="Fujian Provincial Key Laboratory of Tumor Biotherapy, Fuzhou, 350014 Fujian China">
<meta name="citation_publication_date" content="2025 Aug 23">
<meta name="citation_volume" content="25">
<meta name="citation_firstpage" content="1361">
<meta name="citation_doi" content="10.1186/s12903-025-06733-5">
<meta name="citation_pmid" content="40849665">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374416/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374416/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374416/pdf/12903_2025_Article_6733.pdf">
<meta name="description" content="Epstein-Barr virus-encoded small RNA (EBER) in situ hybridization is the primary biomarker assay employed to infer Epstein-Barr virus (EBV) involvement in nasopharyngeal carcinoma (NPC). However, discordance between EBER status and EBV DNA detection ...">
<meta name="og:title" content="Prognostic implications of EBER and EBV DNA combinations in nasopharyngeal carcinoma in endemic areas">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Epstein-Barr virus-encoded small RNA (EBER) in situ hybridization is the primary biomarker assay employed to infer Epstein-Barr virus (EBV) involvement in nasopharyngeal carcinoma (NPC). However, discordance between EBER status and EBV DNA detection ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374416/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12374416">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s12903-025-06733-5"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/12903_2025_Article_6733.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12374416%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12374416/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12374416/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374416/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-bmcorhl.png" alt="BMC Oral Health logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to BMC Oral Health" title="Link to BMC Oral Health" shape="default" href="https://bmcoralhealth.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">BMC Oral Health</button></div>. 2025 Aug 23;25:1361. doi: <a href="https://doi.org/10.1186/s12903-025-06733-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s12903-025-06733-5</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22BMC%20Oral%20Health%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22BMC%20Oral%20Health%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22BMC%20Oral%20Health%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22BMC%20Oral%20Health%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Prognostic implications of EBER and EBV DNA combinations in nasopharyngeal carcinoma in endemic areas</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Ying Li</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Ying Li</span></h3>
<div class="p">
<sup>1</sup>Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Ying Li</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Lishui Wu</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Lishui Wu</span></h3>
<div class="p">
<sup>1</sup>Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lishui Wu</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Zongwei Huang</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Zongwei Huang</span></h3>
<div class="p">
<sup>1</sup>Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zongwei Huang</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cai%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Sunqiu Cai</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Sunqiu Cai</span></h3>
<div class="p">
<sup>2</sup>Department of Radiation Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000 Fujian China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cai%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sunqiu Cai</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Siqi Xu</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Siqi Xu</span></h3>
<div class="p">
<sup>1</sup>Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xu%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Siqi Xu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Jue Wang</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Jue Wang</span></h3>
<div class="p">
<sup>1</sup>Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jue Wang</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Yuxin Yu</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Yuxin Yu</span></h3>
<div class="p">
<sup>1</sup>Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yu%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yuxin Yu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lai%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Jinghua Lai</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Jinghua Lai</span></h3>
<div class="p">
<sup>1</sup>Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lai%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jinghua Lai</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hu%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Dan Hu</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Dan Hu</span></h3>
<div class="p">
<sup>3</sup>Department of Pathology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hu%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Dan Hu</span></a>
</div>
</div>
<sup>3,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Qiu%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Sufang Qiu</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Sufang Qiu</span></h3>
<div class="p">
<sup>1</sup>Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014 China </div>
<div class="p">
<sup>4</sup>Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, 350014 Fujian China </div>
<div class="p">
<sup>5</sup>Fujian Provincial Key Laboratory of Tumor Biotherapy, Fuzhou, 350014 Fujian China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Qiu%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sufang Qiu</span></a>
</div>
</div>
<sup>1,</sup><sup>4,</sup><sup>5,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Radiation Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014 China </div>
<div id="Aff2">
<sup>2</sup>Department of Radiation Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000 Fujian China </div>
<div id="Aff3">
<sup>3</sup>Department of Pathology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014 China </div>
<div id="Aff4">
<sup>4</sup>Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, 350014 Fujian China </div>
<div id="Aff5">
<sup>5</sup>Fujian Provincial Key Laboratory of Tumor Biotherapy, Fuzhou, 350014 Fujian China </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Oct 23; Accepted 2025 Jul 30; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12374416  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40849665/" class="usa-link">40849665</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">Epstein-Barr virus-encoded small RNA (EBER) in situ hybridization is the primary biomarker assay employed to infer Epstein-Barr virus (EBV) involvement in nasopharyngeal carcinoma (NPC). However, discordance between EBER status and EBV DNA detection has been observed in certain NPC patients. This study aims to investigate the prognostic significance of EBER and EBV DNA status.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p id="Par2">A total of 2,942 NPC patients with known EBV status, treated at our center between 2016 and 2022, were included in this analysis. Clinical characteristics and survival outcomes were compared between patients who had EBER-negative versus EBER-positive and who were matched in a 1:4 ratio. The Kaplan-Meier method was used to analyze survival data. The association between EBER-EBV DNA status and survival outcomes was assessed using multivariable analysis.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p id="Par3">Among the cohort, 51 patients (1.7%) were EBER-negative, while 2,891 patients (98.3%) were EBER-positive. EBV-negative NPC was significantly associated with the keratinizing subtype (15.7% vs. 0.3%, <em>P</em> &lt; 0.001). EBER-negative patients exhibited a higher propensity for locoregional recurrence compared to their EBER-positive counterparts, with a 5-year locoregional failure-free survival rate of 76.5% (95% CI, 63.3%-92.5%) versus 86.8% (95% CI, 85.0%-88.6%), respectively (<em>P</em> = 0.012). Multivariable analysis further identified a significant association between double-negative status (EBER-/EBV DNA-) and an increased risk of locoregional recurrence (HR: 4.368, 95% CI, 2.058–9.269, <em>P</em> &lt; 0.001), compared to the double-positive one. These associations remained robust after adjustment for confounding factors and in repeated analyses of the matched cohort.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusions</h3>
<p id="Par4">This study highlights the potential prognostic value of EBER and EBV DNA combinations in NPC. However, given the limited number of EBV-negative cases, further investigations are warranted to substantiate these findings.</p></section><section id="sec5"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s12903-025-06733-5.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Nasopharyngeal carcinoma, Epstein-Barr virus, EBER, EBV DNA, Prognosis</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par19">Nasopharyngeal carcinoma (NPC) is a distinctive malignancy that differs from other epithelial cancers of the head and neck in its geographical and demographic distribution, with a marked prevalence in China and Southeast Asia [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. The endemic variant of NPC demonstrates a robust association with Epstein-Barr virus (EBV) infection and is predominantly characterized by an undifferentiated histological subtype [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>, <a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. In contrast, in non-endemic regions, where the incidence of NPC is significantly lower (age-standardized incidence rate &lt; 3 per 100,000 person-years), the disease tends to present with keratinizing squamous histomorphology [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Notably, EBV is frequently detected in NPC cases across worldwide, with a prevalence of EBV positivity in approximately 95% of cases in endemic regions, compared to around 86% in non-endemic regions [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>–<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>].</p>
<p id="Par20">Some evidence supports the involvement of EBV in the etiology of NPC, as evidenced by the detection of viral DNA within tumor cells and the display of viral antigens on the surface of neoplastic cells [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. EBV-encoded small RNA (EBER), a key molecular marker, is universally expressed across all known latency states of EBV, providing a reliable target for viral detection in clinical specimens [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. The detection of EBER through in situ hybridization (ISH) remains the gold standard for identifying latent EBV infection [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. Recent advances in NPC treatment have been driven by insights from large-scale prospective clinical trials and retrospective studies exploring various therapeutic approaches [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>, <a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. Notably, Du et al. proposed a refined staging system tailored to EBV-associated NPC in endemic regions [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. However, its applicability to EBV-negative NPC remains to be determined.</p>
<p id="Par21">Previous studies on EBV-negative NPC have primarily focused on its clinicopathological features and prognosis [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>, <a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. EBER positivity has generally been associated with improved prognosis, particularly in endemic regions [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>–<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. However, findings by Xiong et al. indicated that EBV-positive NPC patients are more likely to experience local recurrence compared to their EBV-negative counterparts [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. Conversely, in low-incidence regions, no statistically significant associations were observed between EBER expression and overall survival or progression-free survival [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. Additionally, clinical practice reveals inconsistencies between EBER and EBV DNA status exist in certain NPC cases. The prognostic significance of varying EBER and EBV DNA profiles in NPC remains uncertain and warrants further investigation.</p>
<p id="Par22">In light of this, we conducted a retrospective analysis to explore the gaps regarding the prognostic implications of various EBER and EBV DNA combinations in NPC. These data have the potential to deepen the understanding of non-EBV infection NPC and contribute to strengthening clinical management of NPC in endemic areas.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Study design and participants</h3>
<p id="Par23">We conducted a retrospective analysis of NPC patients who were initially diagnosed at Fujian Cancer Hospital, China, between Jan. 2016 and Dec. 2022. The study cohort included patients with histologically confirmed primary squamous cell carcinoma of the nasopharynx, for whom data on EBER status (assessed by ISH) and EBV DNA quantification (measured by polymerase chain reaction) were available. All patients underwent cross-sectional imaging, biopsy for histological confirmation and received complete treatment with radical IMRT, with a subset also receiving chemotherapy. Exclusion criteria included the presence of distant metastasis at initial diagnosis, incomplete baseline data, prior anti-tumor treatment, treatment abandonment, or loss to follow-up (defined as no follow-up data available after therapy). The study was conducted in accordance with the principles of the Declaration of Helsinki and approved by the Ethics Committee of Fujian Cancer Hospital (No. K2024-311-01). Owing to its retrospective design, no additional informed consent from patients was required.</p></section><section id="Sec4"><h3 class="pmc_sec_title">Variables and outcome measures</h3>
<p id="Par24">Baseline and treatment-related characteristics were extracted from the medical records of each patient, including age, gender, TNM stage, histological subtype, EBER status, plasma EBV DNA load, treatment details, and clinical outcomes. To explore potential alternative biomarkers for patients with double-negative profiles, we included the immune inflammation index (III) and nutrition index (NI), derived from our previous research, which were identified as prognostic factors for EBV DNA-negative NPC in our previous research [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. The methodologies for calculating the III and NI have been described elsewhere [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. Clinical outcomes encompassed the date of last follow-up, recurrence, metastasis, or death. Staging for all patients was reassessed by Dr. Li and Dr. Huang from the Department of Oncology using the American Joint Committee on Cancer 8th edition staging system for NPC. All patients underwent radical IMRT, with treatment details provided in our earlier publication [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>].</p>
<p id="Par25">The study focused on two outcomes. The first outcome was the distribution of various combinations of EBER and EBV DNA status within the cohort. The second was locoregional failure-free survival (LRFFS), defined as the time interval from the completion of IMRT to the first occurrence of local or regional recurrence, or the last follow-up. Secondary outcomes included overall survival (OS), measured from the completion of IMRT to either death or the last follow-up. The final follow-up was conducted on July 20, 2024. Patients were regularly monitored through outpatient clinic visits or maintained contact via phone, with meticulous documentation of any cancer recurrences or mortality events.</p></section><section id="Sec5"><h3 class="pmc_sec_title">Epstein-Barr virus detection</h3>
<p id="Par26">The tissue wax blocks were subjected to EBER in situ hybridization to assess the EBV status of the tumors [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. ISH was performed using the EBER Probe ISH Detection Kit<sup>®</sup> (Taipu Bioscience Co., Ltd, China), in strict accordance with the manufacturer’s protocol, ensuring consistent application across all samples. Specimens underwent pretreatment with proteinase K, followed by the addition of a hybridization solution containing a fluorescein-labeled EBV nucleic acid probe. Subsequent to hybridization, an alkaline phosphatase-conjugated antibody targeting fluorescein isothiocyanate was applied, and the chromogenic reaction was developed using a mixture of 5-bromo-4-chloro-3-indolyl-phosphate and 4-nitro-blue tetrazolium chloride, with levamisole included to inhibit nonspecific staining. The slides were then counterstained with hematoxylin. EBER-positive NPC was identified by the presence of blue-purple granules within the nuclei, with the cytoplasm remained unstained. Conversely, samples without these nuclear granules were classified as EBER-negative NPC. ISH results were independently assessed by Dr. Hu, an experienced pathologist, using high-magnification microscopy. Representative pathological images of one EBER-positive and one EBER-negative patient are shown in Fig. <a href="#Fig1" class="usa-link">1</a>.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374416_12903_2025_6733_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1910/12374416/4a0325d1ee59/12903_2025_6733_Fig2_HTML.jpg" loading="lazy" id="d33e455" height="571" width="669" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>In situ hybridization against EBER. <strong>A</strong> EBER-negative and (<strong>B</strong>) EBER-positive NPC tissues detected by hematoxylin-eosin staining and in situ hybridization. EBER, Epstein-Barr virus encoded small RNA; HE, hematoxylin-eosin; ISH, in situ hybridization; NPC, nasopharyngeal carcinoma</p></figcaption></figure><p id="Par28">All NPCs in this study were classified as either keratinizing squamous cell carcinoma or non-keratinizing carcinoma. For EBER-negative patients, additional p16 immunohistochemical staining (a positive result indicating diffuse cytoplasmic and nuclear staining in &gt; 70% of tumor cells) was performed to assess human papillomavirus (HPV) status, supplemented by real-time polymerase chain reaction (PCR) of DNA for high-risk HPV in some cases [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>].</p></section><section id="Sec6"><h3 class="pmc_sec_title">Plasma EBV DNA quantitation</h3>
<p id="Par29">EBV DNA quantification was performed using a real-time quantitative PCR assay targeting the highly conserved BamHI-W region of the EBV genome [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. This assay employed a test kit from Daan Gene Co., Ltd., Sun Yat-sen University (Guangzhou, China). Plasma samples were collected, and DNA extraction was carried out using magnetic bead technology (EA20160201, PerkinElmer) in conjunction with an automated nucleic acid extraction workstation (Pre-NAT, PerkinElmer). The BamHI-W region of the extracted DNA was then amplified to measure circulating EBV DNA concentrations. Patients were classified as EBV DNA negative if their plasma EBV DNA load was 0 copies/mL at all three time points assessed: upon admission, prior to radiotherapy, and after radiotherapy, as previously defined [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>].</p></section><section id="Sec7"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par30">Descriptive statistics were computed for all collected variables, with comparisons made using the Chi-squared test and the Kruskal-Wallis test. Univariate and multivariate Cox regression analyses were conducted to identify potential prognostic factors. Survival rates were estimated using the Kaplan-Meier method, with differences between groups evaluated via the log-rank test. Propensity score matching (PSM) was employed to address selection bias in estimating EBER status, as reflected by a markedly low number of patients with negative EBER status compared to those with positive EBER status. Matching was conducted based on all relevant confounding variables using the nearest neighbor algorithm, with a caliper value of 0.25 and a 1:4 matching ratio. The balance of covariates before and after PSM was assessed using the standardized mean difference (SMD), with values &lt; 0.1 indicating balance. Multivariable analysis was conducted to evaluate the impact of the EBER-EBV DNA combination on survival outcomes in both the entire and PSM cohorts, using three distinct regression models, each adjusting for distinct covariates to mitigate potential confounding biases. Model 1 adjusted for demographic variables, including age and gender; Model 2 further incorporated tumor characteristics, such as T category, N category, and histology; and Model 3 additionally accounted for treatment-related factors, including induction and concurrent chemotherapy. Analyses were performed using R software v4.3.0, Zstats v1.0 (<a href="http://www.zstats.net" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.zstats.net</a>), and SPSS Statistics v25.0, with a significance threshold set at a two-tailed <em>P</em>-value &lt; 0.05.</p></section></section><section id="Sec8"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec9"><h3 class="pmc_sec_title">Clinical characteristics</h3>
<p id="Par31">Our initial cohort comprised 4,925 non-metastatic NPC patients with well-defined staging who underwent radical IMRT. Of these, 1,983 patients were excluded: 1,862 lacked EBER or plasma EBV DNA data during treatment, 66 were not classified into keratinizing or non-keratinizing histological subtypes, 52 had missing follow-up data, and 3 experienced disease progression during treatment. Consequently, 2,942 patients were included for the final analysis (Fig. <a href="#Fig2" class="usa-link">2</a>). The median age of the cohort was 49 years (range, 8 to 87) (Table <a href="#Tab1" class="usa-link">1</a>). Among the 2,942 patients, 438 patients (14.9%) had early-stage disease (stage I-II), while 2,504 patients (85.1%) presented with locally advanced disease (stage III and IVa) at diagnosis. The non-keratinizing pathological subtype was predominant, observed in 99.5% of cases. In comparison to EBER-positive NPC patients (<em>n</em> = 2,891), those with EBER-negative were more likely to be female (41.2% vs. 26.4%, <em>P</em> = 0.018), had a higher incidence of the keratinizing subtype (15.7% vs. 0.3%, <em>P</em> &lt; 0.001), and were more likely to be EBV DNA-negative (47.1% vs. 6.8%, <em>P</em> &lt; 0.001) (Table<a href="#MOESM1" class="usa-link"><strong>S1</strong></a>). Of the 51 patients with EBER-negative NPC, p16 immunohistochemical staining was conducted on 39 tumor samples, while the remaining samples that PCR confirmed the absence of HPV DNA, revealing 3 p16-positive tumors (2 in double-nagetive group and 1 in EBER-/EBV DNA + group), classified as HPV-positive NPC. The overall median follow-up time was 32 months (range, 3 to 96 months). The EBER-negative group exhibited a significantly poorer 5-year LRFFS rate than the EBER-positive group (76.5% [95% CI, 63.3%−92.5%] vs. 86.8% [95% CI, 85.0%−88.6%], <em>P</em> = 0.012, Fig. <a href="#Fig3" class="usa-link">3</a>A), with a marginal effect on OS (82.0% [95% CI, 70.3%−95.6%] vs. 86.6% [95% CI, 84.7%−88.7%], <em>P</em> = 0.066, Fig. <a href="#Fig3" class="usa-link">3</a>B).</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374416_12903_2025_6733_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1910/12374416/2317f426f95d/12903_2025_6733_Fig1_HTML.jpg" loading="lazy" id="d33e535" height="608" width="669" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The flowchart of the patient inclusion</p></figcaption></figure><section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Baseline characteristics of patients with nasopharyngeal carcinoma according to each EBER-EBV DNA combination group</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Characteristic</th>
<th align="left" colspan="1" rowspan="1">EBER-/EBV DNA-<br>(<em>n</em> = 24)</th>
<th align="left" colspan="1" rowspan="1">EBER-/EBV DNA+<br>(<em>n</em> = 27)</th>
<th align="left" colspan="1" rowspan="1">EBER+/EBV DNA-<br>(<em>n</em> = 195)</th>
<th align="left" colspan="1" rowspan="1">EBER+/EBV DNA+<br>(<em>n</em> = 2696)</th>
<th align="left" colspan="1" rowspan="1">
<em>P</em> value</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Age, Median with range, years</td>
<td align="left" colspan="1" rowspan="1">51.5 (31–67)</td>
<td align="left" colspan="1" rowspan="1">50 (25–74)</td>
<td align="left" colspan="1" rowspan="1">51 (23–78)</td>
<td align="left" colspan="1" rowspan="1">49 (8–87)</td>
<td align="left" colspan="1" rowspan="1">0.587</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Gender, No. (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">0.066</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Male</td>
<td align="left" colspan="1" rowspan="1">15 (62.5)</td>
<td align="left" colspan="1" rowspan="1">15 (55.6)</td>
<td align="left" colspan="1" rowspan="1">137 (70.3)</td>
<td align="left" colspan="1" rowspan="1">1992 (73.9)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female</td>
<td align="left" colspan="1" rowspan="1">9 (37.5)</td>
<td align="left" colspan="1" rowspan="1">12 (44.4)</td>
<td align="left" colspan="1" rowspan="1">58 (29.7)</td>
<td align="left" colspan="1" rowspan="1">704 (26.1)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Histology, No. (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Keratinizing</td>
<td align="left" colspan="1" rowspan="1">7 (29.2)</td>
<td align="left" colspan="1" rowspan="1">1 (3.7)</td>
<td align="left" colspan="1" rowspan="1">0 (0.0)</td>
<td align="left" colspan="1" rowspan="1">8 (0.3)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Nonkeratinizing</td>
<td align="left" colspan="1" rowspan="1">17 (70.8)</td>
<td align="left" colspan="1" rowspan="1">26 (96.3)</td>
<td align="left" colspan="1" rowspan="1">195 (100.0)</td>
<td align="left" colspan="1" rowspan="1">2688 (99.7)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">T category, No. (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">T0-1</td>
<td align="left" colspan="1" rowspan="1">3 (12.5)</td>
<td align="left" colspan="1" rowspan="1">5 (18.5)</td>
<td align="left" colspan="1" rowspan="1">65 (33.3)</td>
<td align="left" colspan="1" rowspan="1">482 (17.9)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">T2</td>
<td align="left" colspan="1" rowspan="1">3 (12.5)</td>
<td align="left" colspan="1" rowspan="1">5 (18.5)</td>
<td align="left" colspan="1" rowspan="1">36 (18.5)</td>
<td align="left" colspan="1" rowspan="1">432 (16.0)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">T3</td>
<td align="left" colspan="1" rowspan="1">13 (54.2)</td>
<td align="left" colspan="1" rowspan="1">10 (37.0)</td>
<td align="left" colspan="1" rowspan="1">68 (34.9)</td>
<td align="left" colspan="1" rowspan="1">1150 (42.7)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">T4</td>
<td align="left" colspan="1" rowspan="1">5 (20.8)</td>
<td align="left" colspan="1" rowspan="1">7 (25.9)</td>
<td align="left" colspan="1" rowspan="1">26 (13.3)</td>
<td align="left" colspan="1" rowspan="1">632 (23.4)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">N category, No. (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">N0</td>
<td align="left" colspan="1" rowspan="1">2 (8.3)</td>
<td align="left" colspan="1" rowspan="1">1 (3.7)</td>
<td align="left" colspan="1" rowspan="1">46 (23.6)</td>
<td align="left" colspan="1" rowspan="1">210 (7.8)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">N1</td>
<td align="left" colspan="1" rowspan="1">12 (50.0)</td>
<td align="left" colspan="1" rowspan="1">13 (48.2)</td>
<td align="left" colspan="1" rowspan="1">100 (51.3)</td>
<td align="left" colspan="1" rowspan="1">1077 (40.0)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">N2</td>
<td align="left" colspan="1" rowspan="1">6 (25.0)</td>
<td align="left" colspan="1" rowspan="1">11 (40.7)</td>
<td align="left" colspan="1" rowspan="1">41 (21.0)</td>
<td align="left" colspan="1" rowspan="1">822 (30.5)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">N3</td>
<td align="left" colspan="1" rowspan="1">4 (16.7)</td>
<td align="left" colspan="1" rowspan="1">2 (7.4)</td>
<td align="left" colspan="1" rowspan="1">8 (4.1)</td>
<td align="left" colspan="1" rowspan="1">587 (21.8)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Stage, No. (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Stage I</td>
<td align="left" colspan="1" rowspan="1">0 (0.0)</td>
<td align="left" colspan="1" rowspan="1">0 (0.0)</td>
<td align="left" colspan="1" rowspan="1">17 (8.7)</td>
<td align="left" colspan="1" rowspan="1">50 (1.9)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Stage II</td>
<td align="left" colspan="1" rowspan="1">3 (12.5)</td>
<td align="left" colspan="1" rowspan="1">3 (11.1)</td>
<td align="left" colspan="1" rowspan="1">53 (27.2)</td>
<td align="left" colspan="1" rowspan="1">312 (11.6)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Stage III</td>
<td align="left" colspan="1" rowspan="1">11 (45.8)</td>
<td align="left" colspan="1" rowspan="1">15 (55.6)</td>
<td align="left" colspan="1" rowspan="1">90 (46.2)</td>
<td align="left" colspan="1" rowspan="1">1194 (44.3)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Stage IVa</td>
<td align="left" colspan="1" rowspan="1">10 (41.7)</td>
<td align="left" colspan="1" rowspan="1">9 (33.3)</td>
<td align="left" colspan="1" rowspan="1">35 (18.0)</td>
<td align="left" colspan="1" rowspan="1">1140 (42.3)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">EBV DNA, pre-treatment, copies/mL</td>
<td align="left" colspan="1" rowspan="1">0 (0, 0)</td>
<td align="left" colspan="1" rowspan="1">780 (120, 3395)</td>
<td align="left" colspan="1" rowspan="1">0 (0, 0)</td>
<td align="left" colspan="1" rowspan="1">2110 (392, 10800)</td>
<td align="left" colspan="1" rowspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">EBV DNA, pre-RT, copies/mL</td>
<td align="left" colspan="1" rowspan="1">0 (0, 0)</td>
<td align="left" colspan="1" rowspan="1">83.65 (0, 512.25)</td>
<td align="left" colspan="1" rowspan="1">0 (0, 0)</td>
<td align="left" colspan="1" rowspan="1">30.7 (0, 355)</td>
<td align="left" colspan="1" rowspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">EBV DNA, post-RT, copies/mL</td>
<td align="left" colspan="1" rowspan="1">0 (0, 0)</td>
<td align="left" colspan="1" rowspan="1">0 (0, 0)</td>
<td align="left" colspan="1" rowspan="1">0 (0, 0)</td>
<td align="left" colspan="1" rowspan="1">0 (0, 0)</td>
<td align="left" colspan="1" rowspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Received induction chemotherapy, No. (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">&lt; 0.001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">4 (16.7)</td>
<td align="left" colspan="1" rowspan="1">2 (7.4)</td>
<td align="left" colspan="1" rowspan="1">72 (36.9)</td>
<td align="left" colspan="1" rowspan="1">362 (13.4)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Yes</td>
<td align="left" colspan="1" rowspan="1">20 (83.3)</td>
<td align="left" colspan="1" rowspan="1">25 (92.6)</td>
<td align="left" colspan="1" rowspan="1">123 (63.1)</td>
<td align="left" colspan="1" rowspan="1">2334 (86.6)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Received concurrent chemotherapy, No. (%)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">0.314</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">14 (58.3)</td>
<td align="left" colspan="1" rowspan="1">9 (33.3)</td>
<td align="left" colspan="1" rowspan="1">86 (44.1)</td>
<td align="left" colspan="1" rowspan="1">1247 (46.3)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Yes</td>
<td align="left" colspan="1" rowspan="1">10 (41.7)</td>
<td align="left" colspan="1" rowspan="1">18 (66.7)</td>
<td align="left" colspan="1" rowspan="1">109 (55.9)</td>
<td align="left" colspan="1" rowspan="1">1449 (53.8)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr><td align="left" colspan="6" rowspan="1">5-year outcomes: actuarial rate (95% CI), %</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> LRFFS</td>
<td align="left" colspan="1" rowspan="1">63.7 (44.4–91.3)</td>
<td align="left" colspan="1" rowspan="1">87.8 (72.7–100.0)</td>
<td align="left" colspan="1" rowspan="1">92.5 (87.9–97.4)</td>
<td align="left" colspan="1" rowspan="1">86.3 (84.3–88.3)</td>
<td align="left" colspan="1" rowspan="1">0.003</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> OS</td>
<td align="left" colspan="1" rowspan="1">75.5 (56.4–100.0)</td>
<td align="left" colspan="1" rowspan="1">86.1 (72.3–100.0)</td>
<td align="left" colspan="1" rowspan="1">94.6 (90.4–99.1)</td>
<td align="left" colspan="1" rowspan="1">86.0 (83.8–88.1)</td>
<td align="left" colspan="1" rowspan="1">0.012</td>
</tr>
<tr><td align="left" colspan="6" rowspan="1">
<em>EBER</em>, EBV-encoded small RNA; <em>EBV</em>, Epstein-Barr virus; <em>LRFFS</em>, locoregional failure-free survival; <em>OS</em>, overall survival; <em>RT</em>, radiotherapy</td></tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12374416_12903_2025_6733_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1910/12374416/ba5808de1a22/12903_2025_6733_Fig3_HTML.jpg" loading="lazy" id="d33e1023" height="836" width="669" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Prognostic outcomes in patients with nasopharyngeal carcinoma stratified by EBER status are presented. <strong>A</strong> The locoregional failure-free survival and (<strong>B</strong>) overall survival for the whole cohort between EBER-positive and EBER-negative groups. <strong>C</strong> The locoregional failure-free survival and (<strong>D</strong>) overall survival in the propensity score-matched cohort. <strong>E</strong> A representative patient with EBER-/EBV DNA-; more than 1 year after treatment, the patient developed local and regional recurrence. <strong>F</strong> A representative patient with EBER+/EBV DNA+; after a follow-up period of over 6 years, there was no evidence of locoregional recurrence or distant metastasis. EBER, Epstein-Barr virus encoded small RNA; EBV DNA, Epstein-Barr virus DNA</p></figcaption></figure></section><section id="Sec10"><h3 class="pmc_sec_title">Subgroup analysis of EBER-EBV DNA combinations</h3>
<p id="Par35">Among the 2,942 patients with available EBER and EBV DNA test results, 2,696 (91.6%) were classified as EBER+/EBV DNA+ (double positive), 24 (0.8%) as EBER-/EBV DNA- (double negative), 195 (6.6%) as EBER+/EBV DNA-, and 27 (0.9%) as EBER-/EBV DNA+. Table <a href="#Tab1" class="usa-link">1</a> summarizes the clinical and demographic characteristics of patients stratified by EBER-EBV DNA status combinations. Notably, significant differences were observed in histological subtypes, with the double-negative subgroup demonstrating a substantially higher proportion of keratinizing carcinomas compared to other groups (<em>P</em> &lt; 0.001). Differences were also apparent in TNM staging and the administration of induction chemotherapy (<em>P</em> &lt; 0.001).</p>
<p id="Par36">Patients in the double-negative subgroup exhibited a markedly increased risk of locoregional recurrence compared to the double-positive subgroup (5-year LRFFS rate: 63.7% [95% CI, 44.4%−91.3%] vs. 82.9% [95% CI, 80.4%−85.5%], <em>P</em> &lt; 0.001), the EBER+/EBV NDA- subgroup (5-year LRFFS rate: 63.7% [95% CI, 44.4%−91.3%] vs. 87.8% [95% CI, 72.7%−100.0%], <em>P</em> = 0.023) and the EBER-/EBV NDA + subgroup (5-year LRFFS rate: 63.7% [95% CI, 44.4%−91.3%] vs. 92.5% [95% CI, 87.9%−97.4%], <em>P</em> &lt; 0.001). Additionally, the double-negative group demonstrated a significantly higher risk of mortality compared to the double-positive group (5-year OS rate: 75.5% [95% CI, 56.4%−100.0%] vs. 86.0% [95% CI, 83.8%−88.1%], <em>P</em> = 0.033). Furthermore, patients in the EBER+/EBV DNA- subgroup displayed superior survival outcomes relative to the double-positive (5-year OS rate: 94.6% [95% CI, 90.4%−99.1%] vs. 86.0% [95% CI, 83.8%−88.1%], <em>P</em> = 0.016), double-negative (5-year OS rate: 94.6% [95% CI, 90.4%−99.1%] vs. 75.5% [95% CI, 56.4%−100.0%], <em>P</em> &lt; 0.001) and EBER-/EBV NDA + subgroups (5-year OS rate: 94.6% [95% CI, 90.4%−99.1%] vs. 86.1% [95% CI, 72.3%−100.0%], <em>P</em> = 0.046). Similar findings were observed after excluding the three p16-positive patients from the EBER-negative cohort (see Supplementary Results).</p></section><section id="Sec11"><h3 class="pmc_sec_title">Association between EBER-EBV DNA combination and survival outcomes in the entire cohort</h3>
<p id="Par37">To elucidate the association between different subgroups and survival outcome in NPC patients, a multivariable analysis was performed, accounting for potential confounders, including age, gender, histology, T category, N category, and the use of induction and concurrent chemotherapy. Compared to the double-positive group, patients in the double-negative subgroup demonstrated a significantly higher risk of locoregional recurrence (HR: 4.368, 95% CI, 2.058–9.269, <em>P</em> &lt; 0.001 in the unadjusted model, Table <a href="#Tab2" class="usa-link">2</a>). This elevated risk remained significant after adjusting for demographic factors (Model 1, HR: 4.713, 95% CI, 2.215–10.028, <em>P</em> &lt; 0.001), tumor characteristics (Model 2, HR: 3.357, 95% CI, 1.401–8.039, <em>P</em> = 0.007), and further treatment-related confounders (Model 3, HR: 3.588, 95% CI, 1.486–8.659, <em>P</em> = 0.004). These results highlight a strong association between double-negative EBER and EBV DNA status and poor LRFFS in NPC patients. Additionally, the EBER+/EBV DNA- subgroup exhibited a reduced risk of mortality compared to the double-positive group in the unadjusted model (HR: 0.424, 95% CI, 0.209–0.862, <em>P</em> = 0.018) and Model 1 (HR: 0.404, 95% CI, 0.198–0.821, <em>P</em> = 0.012). However, this trend was attenuated and did not reach statistical significance after adjusting for tumor characteristics (HR: 0.522, 95% CI, 0.254–1.073, <em>P</em> = 0.077 in Model 2) and treatment-related factors (HR: 0.511, 95% CI, 0.248–1.050, <em>P</em> = 0.068 in Model 3).</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Association of EBER-EBV DNA combination and survival outcomes in patients with nasopharyngeal carcinoma in the entire cohort</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1">Characteristic</th>
<th align="left" colspan="2" rowspan="1">Non-adjusted</th>
<th align="left" colspan="2" rowspan="1">Model 1</th>
<th align="left" colspan="2" rowspan="1">Model 2</th>
<th align="left" colspan="2" rowspan="1">Model 3</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">HR (95% CI)</th>
<th align="left" colspan="1" rowspan="1">
<em>P</em> value</th>
<th align="left" colspan="1" rowspan="1">HR (95% CI)</th>
<th align="left" colspan="1" rowspan="1">
<em>P</em> value</th>
<th align="left" colspan="1" rowspan="1">HR (95% CI)</th>
<th align="left" colspan="1" rowspan="1"> <em>P</em> value</th>
<th align="left" colspan="1" rowspan="1">HR (95% CI)</th>
<th align="left" colspan="1" rowspan="1">
<em>P</em> value</th>
</tr>
</thead>
<tbody>
<tr><td align="left" colspan="9" rowspan="1">LRFFS</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> EBER+/EBV DNA+</td>
<td align="left" colspan="1" rowspan="1">1.000 (Reference)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">1.000 (Reference)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">1.000 (Reference)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">1.000 (Reference)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> EBER+/EBV DNA-</td>
<td align="left" colspan="1" rowspan="1">0.554 (0.302–1.017)</td>
<td align="left" colspan="1" rowspan="1">0.057</td>
<td align="left" colspan="1" rowspan="1">0.566 (0.308–1.039)</td>
<td align="left" colspan="1" rowspan="1">0.066</td>
<td align="left" colspan="1" rowspan="1">0.669 (0.361–1.241)</td>
<td align="left" colspan="1" rowspan="1">0.202</td>
<td align="left" colspan="1" rowspan="1">0.700 (0.378–1.297)</td>
<td align="left" colspan="1" rowspan="1">0.257</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> EBER-/EBV DNA+</td>
<td align="left" colspan="1" rowspan="1">1.123 (0.359–3.512)</td>
<td align="left" colspan="1" rowspan="1">0.842</td>
<td align="left" colspan="1" rowspan="1">1.194 (0.381–3.738)</td>
<td align="left" colspan="1" rowspan="1">0.761</td>
<td align="left" colspan="1" rowspan="1">1.297 (0.413–4.069)</td>
<td align="left" colspan="1" rowspan="1">0.656</td>
<td align="left" colspan="1" rowspan="1">1.194 (0.380–3.748)</td>
<td align="left" colspan="1" rowspan="1">0.762</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> EBER-/EBV DNA-</td>
<td align="left" colspan="1" rowspan="1">4.368 (2.058–9.269)</td>
<td align="left" colspan="1" rowspan="1">&lt; 0.001</td>
<td align="left" colspan="1" rowspan="1">4.713 (2.215–10.028)</td>
<td align="left" colspan="1" rowspan="1">&lt; 0.001</td>
<td align="left" colspan="1" rowspan="1">3.357 (1.401–8.039)</td>
<td align="left" colspan="1" rowspan="1">0.007</td>
<td align="left" colspan="1" rowspan="1">3.588 (1.486–8.659)</td>
<td align="left" colspan="1" rowspan="1">0.004</td>
</tr>
<tr><td align="left" colspan="9" rowspan="1">OS</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> EBER+/EBV DNA+</td>
<td align="left" colspan="1" rowspan="1">1.000 (Reference)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">1.000 (Reference)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">1.000 (Reference)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">1.000 (Reference)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> EBER+/EBV DNA-</td>
<td align="left" colspan="1" rowspan="1">0.424 (0.209–0.862)</td>
<td align="left" colspan="1" rowspan="1">0.018</td>
<td align="left" colspan="1" rowspan="1">0.404 (0.198–0.821)</td>
<td align="left" colspan="1" rowspan="1">0.012</td>
<td align="left" colspan="1" rowspan="1">0.522 (0.254–1.073)</td>
<td align="left" colspan="1" rowspan="1">0.077</td>
<td align="left" colspan="1" rowspan="1">0.511 (0.248–1.050)</td>
<td align="left" colspan="1" rowspan="1">0.068</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> EBER-/EBV DNA+</td>
<td align="left" colspan="1" rowspan="1">1.441 (0.534–3.885)</td>
<td align="left" colspan="1" rowspan="1">0.471</td>
<td align="left" colspan="1" rowspan="1">1.349 (0.500-3.642)</td>
<td align="left" colspan="1" rowspan="1">0.555</td>
<td align="left" colspan="1" rowspan="1">1.632 (0.601–4.431)</td>
<td align="left" colspan="1" rowspan="1">0.336</td>
<td align="left" colspan="1" rowspan="1">1.649 (0.606–4.490)</td>
<td align="left" colspan="1" rowspan="1">0.328</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> EBER-/EBV DNA-</td>
<td align="left" colspan="1" rowspan="1">2.654 (0.987–7.142)</td>
<td align="left" colspan="1" rowspan="1">0.053</td>
<td align="left" colspan="1" rowspan="1">2.442 (0.906–6.585)</td>
<td align="left" colspan="1" rowspan="1">0.078</td>
<td align="left" colspan="1" rowspan="1">1.604 (0.542–4.749)</td>
<td align="left" colspan="1" rowspan="1">0.394</td>
<td align="left" colspan="1" rowspan="1">1.632 (0.550–4.842)</td>
<td align="left" colspan="1" rowspan="1">0.377</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p31">
<p>Model 1 was adjusted for age and gender</p>
<p>Model 2 was adjusted for age, gender, T category, N category, and histology</p>
<p>Model 3 was adjusted for age, gender, T category, N category, histology, induction and concurrent chemotherapy</p>
<p><em>EBER</em>, EBV-encoded small RNA; <em>EBV</em>, Epstein-Barr virus; <em>LRFFS</em>, locoregional failure-free survival; <em>OS</em>, overall survival</p>
</div></div></section></section><section id="Sec12"><h3 class="pmc_sec_title">Association between EBER-EBV DNA combination and survival outcomes in the propensity-matched cohort</h3>
<p id="Par39">PSM analysis was employed to mitigate the bias associated with EBER status. Considering that the keratinizing subtype is exceptionally rare in NPC cases within our endemic region and is strongly associated with EBER-negative patients, we did not consider this variable in the PSM analysis. After adjusting for age, gender, T category, N category, EBV DNA status, and treatment modality, 199 EBER-positive patients were matched with 51 EBER-negative patients, achieving a well-balanced distribution of clinical and treatment characteristics between the groups (Table S2, Supplementary Fig. <a href="#Fig1" class="usa-link">1</a>). The robustness of these results was maintained when analyses were confined to the PSM cohort. Survival outcomes varied significantly among the different EBER subgroups. The EBER-negative group exhibited a poorer 5-year LRFFS rate (76.5% [95% CI, 63.3%−92.5%] vs. 87.3% [95% CI, 81.4%−93.5%], <em>P</em> = 0.037, Fig. <a href="#Fig3" class="usa-link">3</a>C). Meanwhile, OS also showed a trend toward worse outcomes in the EBER-negative group, albeit without significance (82.0% [95% CI, 70.3%−95.6%] vs. 89.2% [95% CI, 83.7%−95.1%], <em>P</em> = 0.071, Fig. <a href="#Fig3" class="usa-link">3</a>D). Representative outcomes for patients with EBER-negative and EBER-positive status are depicted in Fig. <a href="#Fig3" class="usa-link">3</a>E-F. Multivariable analysis further revealed that patients in the double-negative group faced a significantly higher risk of recurrence compared to those in the double-positive group, even after adjusting for confounding variables (Table S3). These findings underscore the association between double-negative EBER-EBV DNA status and poorer LRFFS in NPC patients.</p></section><section id="Sec13"><h3 class="pmc_sec_title">Clinical characteristics and prognostic factors of EBER-/EBV DNA- patients</h3>
<p id="Par40">The treatment modalities and clinical outcomes of the double-negative cohort are summarized in Table S4. Given the poorer prognosis associated with this subgroup, we investigated potential prognostic factors. Univariate Cox regression analysis revealed significant associations between nonkeratinizing histology (HR: 5.170, 95% CI: 1.124–23.792, <em>P</em> = 0.035), and III (HR: 1.579, 95% CI: 1.113–2.240, <em>P</em> = 0.011), with decreased LRFFS, as presented in Table <a href="#Tab3" class="usa-link">3</a>. However, these associations did not retain statistical significance in multivariate analysis. A similar trend emerged for OS, with nonkeratinizing subtype (HR: 11.490, 95% CI: 1.104-119.619, <em>P</em> = 0.041) and III (HR: 1.672, 95% CI: 1.057–2.645, <em>P</em> = 0.028) demonstrating prognostic significance in univariate analysis. In contrast, T category and N category showed no significant impact on LRFFS or OS (all <em>P</em> &gt; 0.100).</p>
<section class="tw xbox font-sm" id="Tab3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Identification of prognostic factors in EBER-/EBV DNA- patients by univariate and multivariate Cox regression analysis<sup>a</sup></p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1">Characteristic</th>
<th align="left" colspan="2" rowspan="1">Univariate</th>
<th align="left" colspan="2" rowspan="1">Multivariate</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">HR (95% CI)</th>
<th align="left" colspan="1" rowspan="1">
<em>P</em> value</th>
<th align="left" colspan="1" rowspan="1">HR (95% CI)</th>
<th align="left" colspan="1" rowspan="1">
<em>P</em> value</th>
</tr>
</thead>
<tbody>
<tr><td align="left" colspan="5" rowspan="1">LRFFS</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Age (years)</td>
<td align="left" colspan="1" rowspan="1">1.031 (0.959–1.109)</td>
<td align="left" colspan="1" rowspan="1">0.407</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">Gender</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Male</td>
<td align="left" colspan="1" rowspan="1">1.000 (Reference)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Female</td>
<td align="left" colspan="1" rowspan="1">0.441 (0.084–2.306)</td>
<td align="left" colspan="1" rowspan="1">0.332</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">Histology</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Keratinizing</td>
<td align="left" colspan="1" rowspan="1">1.000 (Reference)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">1.000 (Reference)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Nonkeratinizing</td>
<td align="left" colspan="1" rowspan="1">5.170 (1.124–23.792)</td>
<td align="left" colspan="1" rowspan="1">0.035</td>
<td align="left" colspan="1" rowspan="1">2.480 (0.345–17.836)</td>
<td align="left" colspan="1" rowspan="1">0.367</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> T category</td>
<td align="left" colspan="1" rowspan="1">0.983 (0.441–2.192)</td>
<td align="left" colspan="1" rowspan="1">0.967</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> N category</td>
<td align="left" colspan="1" rowspan="1">1.375 (0.604–3.130)</td>
<td align="left" colspan="1" rowspan="1">0.448</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> III <sup>b</sup>
</td>
<td align="left" colspan="1" rowspan="1">1.579 (1.113–2.240)</td>
<td align="left" colspan="1" rowspan="1">0.011</td>
<td align="left" colspan="1" rowspan="1">1.399 (0.917–2.134)</td>
<td align="left" colspan="1" rowspan="1">0.120</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> NI <sup>b</sup>
</td>
<td align="left" colspan="1" rowspan="1">1.174 (0.669–2.061)</td>
<td align="left" colspan="1" rowspan="1">0.576</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">OS</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Age (years)</td>
<td align="left" colspan="1" rowspan="1">1.017 (0.923–1.120)</td>
<td align="left" colspan="1" rowspan="1">0.740</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Gender</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Male</td>
<td align="left" colspan="1" rowspan="1">1.000 (Reference)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Female</td>
<td align="left" colspan="1" rowspan="1">0.333 (0.034–3.271)</td>
<td align="left" colspan="1" rowspan="1">0.346</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">Histology</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Keratinizing</td>
<td align="left" colspan="1" rowspan="1">1.000 (Reference)</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1">1.000 (Reference)</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> Nonkeratinizing</td>
<td align="left" colspan="1" rowspan="1">11.490 (1.104-119.619)</td>
<td align="left" colspan="1" rowspan="1">0.041</td>
<td align="left" colspan="1" rowspan="1">6.060 (0.359–102.200)</td>
<td align="left" colspan="1" rowspan="1">0.211</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> T category</td>
<td align="left" colspan="1" rowspan="1">0.861 (0.321–2.309)</td>
<td align="left" colspan="1" rowspan="1">0.766</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> N category</td>
<td align="left" colspan="1" rowspan="1">1.979 (0.657–5.965)</td>
<td align="left" colspan="1" rowspan="1">0.225</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> III</td>
<td align="left" colspan="1" rowspan="1">1.672 (1.057–2.645)</td>
<td align="left" colspan="1" rowspan="1">0.028</td>
<td align="left" colspan="1" rowspan="1">1.389 (0.832–2.318)</td>
<td align="left" colspan="1" rowspan="1">0.209</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> NI</td>
<td align="left" colspan="1" rowspan="1">1.288 (0.611–2.712)</td>
<td align="left" colspan="1" rowspan="1">0.506</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">
<sup>a</sup>Variable exhibiting a <em>P</em> value less than 0.05 in the univariate Cox regression analysis were futher included in multivariate Cox regression analysis</td></tr>
<tr><td align="left" colspan="5" rowspan="1">
<sup>b</sup>The calculation of III and NI is detailed elsewhere [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]</td></tr>
<tr><td align="left" colspan="5" rowspan="1">
<em>EBER</em>, EBV-encoded small ribonucleic acid; <em>EBV</em>, Epstein-Barr virus; III, immune inflammation index; <em>LRFFS</em>, locoregional failure-free survival; <em>NI</em>, nutrition index; <em>OS</em>, overall survival</td></tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section></section><section id="Sec14"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par42">Although prior studies have explored the long-term outcomes of NPC based on EBV status within the Chinese population, research on the prognostic implications of combined EBER and EBV DNA statuses in endemic regions remains scarce. In this comprehensive cohort of NPC patients, we evaluated the prognostic impact of various EBER and EBV DNA combinations. Our findings indicated that EBER-negative patients are at an elevated risk of recurrence. Specifically, patients with double-negative status exhibited a significantly poorer LRFFS compared to the double-positive group. The findings from the PSM cohort further corroborated the heightened recurrence risk associated with the double-negative subgroup. These results highlight non-EBV-related NPC as a distinct entity, potentially requiring unique management strategy.</p>
<p id="Par43">To our knowledge, this investigation constitutes the most extensive endeavor to date aimed at elucidating the prognostic significance of EBER and EBV DNA combinations in patients afflicted NPC. Previous research by Xiong et al. aggregated data from NPC patients with known EBV status across four hospitals in both endemic and non-endemic regions of China between 2013 and 2021, and identified 48 EBER-negative patients, though the total 48 EBER-negative patients was not disclosed [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. In our cohort, the incidence of EBER-negative NPC was notably low, accounting for only 1.7% (51 of 2,942 patients). However, this rate should be interpreted with caution, as approximately one-third of patients were excluded due to missing EBER testing at enrollment. Furthermore, some studies have reported no significant differences in survival outcomes between EBV-negative and EBV-positive NPC patients [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. In contrast to Xiong et al., who observed a higher risk of local recurrence in EBER-positive NPC patients, our findings indicate that EBER-negative patients face an increased risk of recurrence and exhibit a trend towards shorter OS [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. This discrepancy may partly attributable to regional variability. Xiong et al.’s cohort comprised patients from diverse geographic locations in China, including Guangdong, an area known for its endemic NPC incidence. However, the precise distribution of patients across these regions was not specified. Geographic and environmental variations, including variations in lifestyle, diet, and potentially racial or ethnic backgrounds, may contribute to these differing clinical outcomes [<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>–<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. Furthermore, factors such as smoking and HPV infection, aside from EBV infection, have been implicated in NPC pathogenesis [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. A previous study reported a high attribution of HPV in the EBV-negative NPC subset (29 of 40 NPCs; 73%) in a western cohort [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. In contrast, our cohort revealed only 3 of 51 (5.9%) EBER-negative cases attributable to HPV. Joint analyses of EBV and HPV have demonstrated worse outcomes for EBV/HPV-negative NPC compared to EBV-positive cases, lending partial support to our results [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>, <a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>]. Additionally, Wang et al. identified higher tumor mutation burdens in EBV-negative NPC, suggesting a potential need for intensified local and possibly systemic treatment for EBV-negative NPC patients [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>].</p>
<p id="Par44">Comparative analysis of EBV-positive and EBV-negative NPC cases reveals distinct histological differences between NPC subtypes [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Non-keratinizing NPCs, predominantly observed in endemic regions, are almost universally EBV-positive, while keratinizing NPCs are exceedingly rare in these areas, accounting for less than 1% of cases [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>, <a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. Our findings corroborate this trend, with only 16 cases (0.5% of the total cohort) identified as the keratinizing subtype. Racial variability in NPC histological subtypes is also evident; for instance, in the United States, a substantial proportion of White patients (64.2%) are diagnosed with keratinizing NPC [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. Non-EBV-associated NPC has increasingly been recognized as a distinct pathological entity, which reflecting the complexity of NPC’s histological and biological heterogeneity. Consistent with prior studies, our results show a strong association between EBER-negative NPCs and the keratinizing subtype [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>], underscoring the close relationship between EBV infection and NPC histological classification [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. Additionally, studies have shown that these histological subtypes demonstrate divergent treatment responses; NPCs with nonkeratinizing subtype are notably sensitive to radiotherapy and platinum-based chemotherapy, in contrast to the less radiosensitive and more clinically aggressive keratinizing subtype [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>]. Bossi et al. demonstrated that intensive treatment benefits disease-free survival predominantly in EBER-positive patients, indicating that additional therapeutic interventions may not offer advantages in EBER-negative cases within low-incidence regions [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. However, due to limitations in sample size, our study did not evaluate survival differences across histological subtypes or optimal treatment strategies for EBER subgroups. Further research with larger cohorts is necessary to provide a more comprehensive comparison of survival outcomes and refine therapeutic approaches for these distinct NPC subtypes.</p>
<p id="Par45">EBV DNA, released into peripheral blood from NPC cells through various mechanisms of cell death, serves as a crucial biomarker for assessing tumor burden, biological behavior, and the presence of occult metastatic lesions in NPC and has been also recognized as a unique biomarker for treatment evaluation and prognostic prediction in NPC [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>, <a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>, <a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. In our study, we observed that 7.4% of histologically confirmed NPC patients were negative for plasma EBV DNA. In response to some studies indicated that 15.1–29.3% of NPC patients from endemic regions exhibit undetectable plasma EBV DNA at initial diagnosis [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>, <a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. Le et al. proposed the possibility of non-EBV origins for some NPC cases [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. Our findings provide additional support for this hypothesis, as we found that not all NPCs tested positive EBER ISH signals. However, upon supplementing the analysis with p16 testing for EBV-negative NPC, we found that 94.1% of these cases were not associated with HPV infection. This suggests that the origins of non-EBV-related NPC remain an area requiring further investigation, as additional factors may contribute to its pathogenesis, which may offer valuable insights into distinct molecular pathways and therapeutic strategies. In our study, patients classified in the EBER-/EBV DNA- group displayed poorer prognosis, characterized by a high risk of recurrence. For these patients, alternative biomarkers for treatment monitoring and prognostication are warranted. Several hematological biomarkers have been shown to hold prognostic significance across various malignancies [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. Previous research from our group has highlighted the prognostic value of the immune inflammation index and nutritional index in NPC patients with negative EBV DNA [<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. We further investigated the prognostic factors influencing outcomes in double-negative patients. Our findings tentatively suggest that non-keratinizing subtypes and immunoinflammatory indices are associated with poorer LRFFS and OS. However, these factors were not identified as independent prognostic indicators, which may be due to the relatively small sample size in this cohort.</p>
<p id="Par46">In the EBER-/EBV DNA + group, the presence of detectable EBV DNA is unlikely to be attributable to technical or sampling variations, as all cases were processed in a single laboratory using consistent EBV-targeting methods. However, the presence of plasma EBV DNA does not exclusively indicate active EBV-driven malignancy and could be detected in some cases without clear EBV-associated disease [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. In our study, we focused on the specific population of patients with NPC, an EBV-associated malignancy, within an endemic region where EBV positivity is strongly linked to the pathogenesis of NPC [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>, <a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. EBER is typically a marker for active EBV infection in tumor cells, and its detection through ISH demonstrates the incorporation of the EBV genome into the tumor cells [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>, <a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. However, in the EBER-/EBV DNA + subgroup, the EBV genome may not be efficiently incorporated into the tumor cells, resulting in diminished EBER expression. Nicholls et al. reported that EBER expression is often weak in patients with low plasma EBV DNA levels prior to treatment [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. Moreover, some patients with advanced stage III to IVA disease may show reduced EBV genome incorporation into tumor cells, potentially leading to impaired EBER expression [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. Additionally, issues related to biomarker sensitivity and lead-time effects may also contribute to these observations [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>]. In light of these considerations, our data, within the context of an endemic population, suggest that the presence of EBV DNA in these patients may be biologically plausible. Nevertheless, we acknowledge the possibility that the EBER-/EBV DNA + subgroup could also represent EBV-negative NPC or cases with incidental EBV reactivation unrelated to tumorigenesis. Consequently, the EBER-negative while EBV DNA-positive subpopulation requires further investigation and a more cautious interpretation of its clinical implications, particularly in the context of NPC.</p>
<p id="Par47">Despite our endeavors, it is imperative to acknowledge certain limitations in our study. Primarily, the retrospective design and limited sample size constrain the robustness of our findings. Although we have adjusted for potential confounders and employed PSM analysis to reduce the impact of these factors, the inherent limitations of retrospective data, such as residual confounding from unmeasured variables or missing patient data, may still influence the results. Future prospective studies with more comprehensive data collection and larger sample sizes are needed to validate and extend these findings. Secondly, variability in EBV testing methods (technique or detection time) may affect the replicability of presented results; our study was carried out at a single treatment center, serves to partially addresses this concern. Additionally, the reliance on a limited number of tumor slides from each patient’s formalin-fixed, paraffin-embedded samples for ISH may not fully capture the extent of EBV genome incorporation across all tumor cells, representing another limitation of our approach. We attempted to mitigate this by selecting the most representative slides containing the highest proportion of tumor cells to ensure reliable EBER scoring. Moreover, the absence of EBER test data for some patients may introduce selection bias, and the true incidence of EBER-negative NPC at our center may differ from the reported 1.7%. Future studies with complete testing on patients would be needed to more accurately reflect the true incidence of EBER-negative NPC in endemic regions. Finally, the limited cohort size restricts the ability to perform a robust analysis of optimal treatment strategies for EBV-negative NPC. Larger, adequately powered studies are essential to further investigate and refine treatment strategies, with the potential to offer more personalized and effective management approaches for these patients.</p></section><section id="Sec15"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par48">In conclusion, this study highlights the potential prognostic value of EBER and EBV DNA combinations in NPC. Given the established role of EBV infection in NPC, these findings provide a reference for enhancing the clinical management of non-EBV-infected NPC patients within endemic areas.</p></section><section id="Sec16"><h2 class="pmc_sec_title">Supplementary Information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12374416/bin/12903_2025_6733_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1.</a><sup> (124.6KB, docx) </sup>
</div></div></section></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>EBER</dt>
<dd><p id="Par5">Epstein-Barr virus-encoded small RNA</p></dd>
<dt>EBV</dt>
<dd><p id="Par6">Epstein-Barr virus</p></dd>
<dt>HPV</dt>
<dd><p id="Par7">Human papillomavirus</p></dd>
<dt>HR</dt>
<dd><p id="Par8">Hazard ratio</p></dd>
<dt>III</dt>
<dd><p id="Par9">Immune inflammation index</p></dd>
<dt>ISH</dt>
<dd><p id="Par10">In situ hybridization</p></dd>
<dt>IMRT</dt>
<dd><p id="Par11">Intensity-modulated radiotherapy</p></dd>
<dt>LRFFS</dt>
<dd><p id="Par12">Locoregional failure-free survival</p></dd>
<dt>NI</dt>
<dd><p id="Par13">Nutrition index</p></dd>
<dt>NPC</dt>
<dd><p id="Par14">Nasopharyngeal carcinoma</p></dd>
<dt>OS</dt>
<dd><p id="Par15">Overall survival</p></dd>
<dt>PCR</dt>
<dd><p id="Par16">Polymerase chain reaction</p></dd>
<dt>PSM</dt>
<dd><p id="Par17">Propensity score matching</p></dd>
<dt>SMD</dt>
<dd><p id="Par18">Standardized mean difference</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Authors’ contributions</h2>
<p>Qiu S. had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Qiu S., Hu D. Acquisition of data: Xu S., Wang J., Yu Y. Drafting of the manuscript: Li Y., Wu L. Statistical analysis: Huang Z., Cai S. Critical revision of the manuscript for important intellectual content: Qiu S. Obtained funding: Qiu S. Study supervision: Lai J. All authors of this paper have read and approved the final version submitted.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>We thank the support of the grants of Science and Technology Program of Fujian Province, China (2018Y2003); Fujian Provincial Clinical Research Center for Cancer Radiotherapy and Immunotherapy (2020Y2012); Supported by the National Clinical Key Specialty Construction Program (2021); Fujian Clinical Research Center for Radiation and Therapy of Digestive, Respiratory and Genitourinary Malignancies (2021Y2014). National Natural Science Foundation of China (82473376); Major Scientific Research Program for Young and Middle-aged Health Professionals of Fujian Province, China (Grant No.2021ZQNZD010); Joint Funds for the Innovation of Science and Technology, Fujian province (2021Y9196, 2023Y9436); the Qihang Funds of Fujian Medical University (2023QH2050, 2022QH2048); and High-level Talent Training Program of Fujian Cancer Hospital (2022YNG07).</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>Data of this study would not be shared. If necessary, data could be obtained from the corresponding authors.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par49">The reporting of this study conforms to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. This study was approved by the Ethics Committee of Fujian Cancer Hospital (No. K2024-311-01). Due to the retrospective design, no additional informed consent from patients was required.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par50">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1">
<p><strong>Publisher’s Note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div>
<div class="fn p" id="fn2"><p>Ying Li, Lishui Wu and Zongwei Huang contributed equally to this work.</p></div>
</div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Dan Hu, Email: hudan@fjmu.edu.cn.</p>
<p>Sufang Qiu, Email: sufangqiu@fjmu.edu.cn.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Su ZY, Siak PY, Lwin YY, Cheah SC. Epidemiology of nasopharyngeal carcinoma: current insights and future outlook. Cancer Metastasis Rev. 2024;43:919–39.
</cite> [<a href="https://doi.org/10.1007/s10555-024-10176-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38430391/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Su%20ZY,%20Siak%20PY,%20Lwin%20YY,%20Cheah%20SC.%20Epidemiology%20of%20nasopharyngeal%20carcinoma:%20current%20insights%20and%20future%20outlook.%20Cancer%20Metastasis%20Rev.%202024;43:919%E2%80%9339." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Chen YP, Chan ATC, Le QT, et al. Nasopharyngeal carcinoma. Lancet. 2019;394:64–80.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(19)30956-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31178151/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20YP,%20Chan%20ATC,%20Le%20QT,%20et%20al.%20Nasopharyngeal%20carcinoma.%20Lancet.%202019;394:64%E2%80%9380." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Li W, Duan X, Chen X, et al. Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma. Front Immunol. 2023;13:1079515.
</cite> [<a href="https://doi.org/10.3389/fimmu.2022.1079515" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9875085/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36713430/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20W,%20Duan%20X,%20Chen%20X,%20et%20al.%20Immunotherapeutic%20approaches%20in%20EBV-associated%20nasopharyngeal%20carcinoma.%20Front%20Immunol.%202023;13:1079515." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Su ZY, Siak PY, Leong CO, Cheah SC. The role of Epstein-Barr virus in nasopharyngeal carcinoma. Front Microbiol. 2023;14:1116143.
</cite> [<a href="https://doi.org/10.3389/fmicb.2023.1116143" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9947861/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36846758/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Su%20ZY,%20Siak%20PY,%20Leong%20CO,%20Cheah%20SC.%20The%20role%20of%20Epstein-Barr%20virus%20in%20nasopharyngeal%20carcinoma.%20Front%20Microbiol.%202023;14:1116143." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Yuan L, Li S, Chen Q, et al. EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinoma. Cell Death Differ. 2022;29:1513–27.
</cite> [<a href="https://doi.org/10.1038/s41418-022-00939-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9346003/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35105963/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yuan%20L,%20Li%20S,%20Chen%20Q,%20et%20al.%20EBV%20infection-induced%20GPX4%20promotes%20chemoresistance%20and%20tumor%20progression%20in%20nasopharyngeal%20carcinoma.%20Cell%20Death%20Differ.%202022;29:1513%E2%80%9327." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Dias JM, Santana IVV, da Silva VD, Carvalho AL, Arantes L. Analysis of Epstein-barr virus (EBV) and PD-L1 expression in nasopharyngeal carcinoma patients in a non-endemic region. Int J Mol Sci. 2022;23:11720.
</cite> [<a href="https://doi.org/10.3390/ijms231911720" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9569432/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36233023/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dias%20JM,%20Santana%20IVV,%20da%20Silva%20VD,%20Carvalho%20AL,%20Arantes%20L.%20Analysis%20of%20Epstein-barr%20virus%20(EBV)%20and%20PD-L1%20expression%20in%20nasopharyngeal%20carcinoma%20patients%20in%20a%20non-endemic%20region.%20Int%20J%20Mol%20Sci.%202022;23:11720." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Ahmed N, Abusalah M, Farzand A, et al. Updates on Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma: emphasis on the latent gene products of EBV. Medicina (B Aires). 2022;59: 2.</cite> [<a href="https://doi.org/10.3390/medicina59010002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9863520/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36676626/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ahmed%20N,%20Abusalah%20M,%20Farzand%20A,%20et%20al.%20Updates%20on%20Epstein-Barr%20virus%20(EBV)-associated%20nasopharyngeal%20carcinoma:%20emphasis%20on%20the%20latent%20gene%20products%20of%20EBV.%20Medicina%20(B%20Aires).%202022;59:%202." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Weiss LM, Chen YY. <em>EBER</em> in situ hybridization for Epstein-Barr virus. Methods Mol Biol. 2013;999:223–30.
</cite> [<a href="https://doi.org/10.1007/978-1-62703-357-2_16" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23666702/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Weiss%20LM,%20Chen%20YY.%20EBER%20in%20situ%20hybridization%20for%20Epstein-Barr%20virus.%20Methods%20Mol%20Biol.%202013;999:223%E2%80%9330." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>AbuSalah MAH, Gan SH, Al-Hatamleh MAI, Irekeola AA, Shueb RH, Yean Yean C. Recent advances in diagnostic approaches for Epstein-Barr virus. Pathogens. 2020;9: 226.
</cite> [<a href="https://doi.org/10.3390/pathogens9030226" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7157745/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32197545/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?AbuSalah%20MAH,%20Gan%20SH,%20Al-Hatamleh%20MAI,%20Irekeola%20AA,%20Shueb%20RH,%20Yean%20Yean%20C.%20Recent%20advances%20in%20diagnostic%20approaches%20for%20Epstein-Barr%20virus.%20Pathogens.%202020;9:%20226." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Zhang Y, Chen L, Hu GQ, et al. Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma. N Engl J Med. 2019;381:1124–35.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1905287" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31150573/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20Y,%20Chen%20L,%20Hu%20GQ,%20et%20al.%20Gemcitabine%20and%20cisplatin%20induction%20chemotherapy%20in%20nasopharyngeal%20carcinoma.%20N%20Engl%20J%20Med.%202019;381:1124%E2%80%9335." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Tang LL, Guo R, Zhang N, et al. Effect of radiotherapy alone vs radiotherapy with concurrent chemoradiotherapy on survival without disease relapse in patients with low-risk nasopharyngeal carcinoma: a randomized clinical trial. JAMA. 2022;328:728–36.
</cite> [<a href="https://doi.org/10.1001/jama.2022.13997" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9399866/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35997729/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tang%20LL,%20Guo%20R,%20Zhang%20N,%20et%20al.%20Effect%20of%20radiotherapy%20alone%20vs%20radiotherapy%20with%20concurrent%20chemoradiotherapy%20on%20survival%20without%20disease%20relapse%20in%20patients%20with%20low-risk%20nasopharyngeal%20carcinoma:%20a%20randomized%20clinical%20trial.%20JAMA.%202022;328:728%E2%80%9336." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Du XJ, Wang GY, Zhu XD et al. Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinoma. Cancer Cell. 2024;42:464–73.e463.</cite> [<a href="https://doi.org/10.1016/j.ccell.2023.12.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38242125/" class="usa-link">PubMed</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Wei ZG, Hu XL, He Y, et al. Clinical and survival analysis of nasopharyngeal carcinoma with consistently negative Epstein-Barr virus DNA. Head Neck. 2021;43:1465–75.
</cite> [<a href="https://doi.org/10.1002/hed.26608" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33421240/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wei%20ZG,%20Hu%20XL,%20He%20Y,%20et%20al.%20Clinical%20and%20survival%20analysis%20of%20nasopharyngeal%20carcinoma%20with%20consistently%20negative%20Epstein-Barr%20virus%20DNA.%20Head%20Neck.%202021;43:1465%E2%80%9375." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Xiong Y, Yuan M, Liu Z, et al. Long-term outcomes of nasopharyngeal carcinoma by Epstein-Barr virus status in the Chinese population: A multicenter investigation. J Clin Med. 2023;12:3005.
</cite> [<a href="https://doi.org/10.3390/jcm12083005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10145834/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37109338/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xiong%20Y,%20Yuan%20M,%20Liu%20Z,%20et%20al.%20Long-term%20outcomes%20of%20nasopharyngeal%20carcinoma%20by%20Epstein-Barr%20virus%20status%20in%20the%20Chinese%20population:%20A%20multicenter%20investigation.%20J%20Clin%20Med.%202023;12:3005." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Peng H, Chen L, Zhang Y, et al. Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus status. Oncotarget. 2016;7:24208–16.
</cite> [<a href="https://doi.org/10.18632/oncotarget.8144" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5029695/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27008701/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Peng%20H,%20Chen%20L,%20Zhang%20Y,%20et%20al.%20Survival%20analysis%20of%20patients%20with%20advanced-stage%20nasopharyngeal%20carcinoma%20according%20to%20the%20Epstein-Barr%20virus%20status.%20Oncotarget.%202016;7:24208%E2%80%9316." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Tao D, Zhang N, Huang Q, et al. Association of Epstein-Barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinoma. Sci Rep. 2020;10:21976.
</cite> [<a href="https://doi.org/10.1038/s41598-020-78892-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7738521/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33319825/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tao%20D,%20Zhang%20N,%20Huang%20Q,%20et%20al.%20Association%20of%20Epstein-Barr%20virus%20infection%20with%20peripheral%20immune%20parameters%20and%20clinical%20outcome%20in%20advanced%20nasopharyngeal%20carcinoma.%20Sci%20Rep.%202020;10:21976." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Ke K, Wang H, Fu S, et al. Epstein-Barr virus-encoded RNAs as a survival predictor in nasopharyngeal carcinoma. Chin Med J Engl. 2014;127:294–9.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/24438619/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ke%20K,%20Wang%20H,%20Fu%20S,%20et%20al.%20Epstein-Barr%20virus-encoded%20RNAs%20as%20a%20survival%20predictor%20in%20nasopharyngeal%20carcinoma.%20Chin%20Med%20J%20Engl.%202014;127:294%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Weng Y, Wu L, Li Y, et al. Prognostic value of immune-inflammatory and nutrition indicators in non-metastatic nasopharyngeal carcinoma with negative plasma Epstein-Barr virus DNA. Ther Adv Med Oncol. 2024;16:17588359241286489.
</cite> [<a href="https://doi.org/10.1177/17588359241286489" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11472370/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39403452/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Weng%20Y,%20Wu%20L,%20Li%20Y,%20et%20al.%20Prognostic%20value%20of%20immune-inflammatory%20and%20nutrition%20indicators%20in%20non-metastatic%20nasopharyngeal%20carcinoma%20with%20negative%20plasma%20Epstein-Barr%20virus%20DNA.%20Ther%20Adv%20Med%20Oncol.%202024;16:17588359241286489." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Li Y, Chen X, Wu L, et al. Impact of the radiotherapy rhythm on prognosis in nasopharyngeal carcinoma. Ann Med. 2024;56(1): 2407061.
</cite> [<a href="https://doi.org/10.1080/07853890.2024.2407061" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11421160/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39310946/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20Y,%20Chen%20X,%20Wu%20L,%20et%20al.%20Impact%20of%20the%20radiotherapy%20rhythm%20on%20prognosis%20in%20nasopharyngeal%20carcinoma.%20Ann%20Med.%202024;56(1):%202407061." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Tsao SW, Tsang CM, Lo KW. Epstein-Barr virus infection and nasopharyngeal carcinoma. Philos Trans R Soc Lond B Biol Sci. 2017;372: 20160270.
</cite> [<a href="https://doi.org/10.1098/rstb.2016.0270" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5597737/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28893937/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tsao%20SW,%20Tsang%20CM,%20Lo%20KW.%20Epstein-Barr%20virus%20infection%20and%20nasopharyngeal%20carcinoma.%20Philos%20Trans%20R%20Soc%20Lond%20B%20Biol%20Sci.%202017;372:%2020160270." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Lewis JS Jr., Beadle B, Bishop JA, et al. Human papillomavirus testing in head and neck carcinomas: guideline from the college of American pathologists. Arch Pathol Lab Med. 2018;142(5):559–97.</cite> [<a href="https://doi.org/10.5858/arpa.2017-0286-CP" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29251996/" class="usa-link">PubMed</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Huang WB, Chan JYW, Liu DL. Human papillomavirus and world health organization type III nasopharyngeal carcinoma: multicenter study from an endemic area in Southern China. Cancer. 2018;124(3):530–6.
</cite> [<a href="https://doi.org/10.1002/cncr.31031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29072774/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20WB,%20Chan%20JYW,%20Liu%20DL.%20Human%20papillomavirus%20and%20world%20health%20organization%20type%20III%20nasopharyngeal%20carcinoma:%20multicenter%20study%20from%20an%20endemic%20area%20in%20Southern%20China.%20Cancer.%202018;124(3):530%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Shao JY, Li YH, Gao HY, et al. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin a/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Cancer. 2004;100:1162–70.
</cite> [<a href="https://doi.org/10.1002/cncr.20099" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15022282/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shao%20JY,%20Li%20YH,%20Gao%20HY,%20et%20al.%20Comparison%20of%20plasma%20Epstein-Barr%20virus%20(EBV)%20DNA%20levels%20and%20serum%20EBV%20immunoglobulin%20a/virus%20capsid%20antigen%20antibody%20titers%20in%20patients%20with%20nasopharyngeal%20carcinoma.%20Cancer.%202004;100:1162%E2%80%9370." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Simon J, Schroeder L, Ingarfield K, et al. Epstein-Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic country. Int J Cancer. 2020;147:461–71.
</cite> [<a href="https://doi.org/10.1002/ijc.33006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32279316/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Simon%20J,%20Schroeder%20L,%20Ingarfield%20K,%20et%20al.%20Epstein-Barr%20virus%20and%20human%20papillomavirus%20serum%20antibodies%20define%20the%20viral%20status%20of%20nasopharyngeal%20carcinoma%20in%20a%20low%20endemic%20country.%20Int%20J%20Cancer.%202020;147:461%E2%80%9371." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Chen Y, Chang ET, Liu Z, et al. Residence characteristics and risk of nasopharyngeal carcinoma in Southern China: a population-based case-control study. Environ Int. 2021;151: 106455.
</cite> [<a href="https://doi.org/10.1016/j.envint.2021.106455" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33652252/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20Y,%20Chang%20ET,%20Liu%20Z,%20et%20al.%20Residence%20characteristics%20and%20risk%20of%20nasopharyngeal%20carcinoma%20in%20Southern%20China:%20a%20population-based%20case-control%20study.%20Environ%20Int.%202021;151:%20106455." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Di W, Yu J, Zong D, et al. Effects of ambient temperature, relative humidity and absolute humidity on risk of nasopharyngeal carcinoma in China. Int J Cancer. 2024;155(4):646–53.
</cite> [<a href="https://doi.org/10.1002/ijc.34933" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38598851/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Di%20W,%20Yu%20J,%20Zong%20D,%20et%20al.%20Effects%20of%20ambient%20temperature,%20relative%20humidity%20and%20absolute%20humidity%20on%20risk%20of%20nasopharyngeal%20carcinoma%20in%20China.%20Int%20J%20Cancer.%202024;155(4):646%E2%80%9353." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Wu S, Liu W, Li H, et al. Conservation and polymorphism of EBV RPMS1 gene in EBV-associated tumors and healthy individuals from endemic and non-endemic nasopharyngeal carcinoma areas in China. Virus Res. 2018;250:75–80.
</cite> [<a href="https://doi.org/10.1016/j.virusres.2018.04.009" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29665370/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20S,%20Liu%20W,%20Li%20H,%20et%20al.%20Conservation%20and%20polymorphism%20of%20EBV%20RPMS1%20gene%20in%20EBV-associated%20tumors%20and%20healthy%20individuals%20from%20endemic%20and%20non-endemic%20nasopharyngeal%20carcinoma%20areas%20in%20China.%20Virus%20Res.%202018;250:75%E2%80%9380." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Huang SH, Jacinto JCK, O’Sullivan B, et al. Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort. Cancer. 2022;128(15):2908–21.
</cite> [<a href="https://doi.org/10.1002/cncr.34266" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35588085/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Huang%20SH,%20Jacinto%20JCK,%20O%E2%80%99Sullivan%20B,%20et%20al.%20Clinical%20presentation%20and%20outcome%20of%20human%20papillomavirus-positive%20nasopharyngeal%20carcinoma%20in%20a%20North%20American%20cohort.%20Cancer.%202022;128(15):2908%E2%80%9321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Dogan S, Hedberg ML, Ferris RL, Rath TJ, Assaad AM, Chiosea SI. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a low-incidence population. Head Neck. 2014;36:511–6.
</cite> [<a href="https://doi.org/10.1002/hed.23318" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4656191/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23780921/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dogan%20S,%20Hedberg%20ML,%20Ferris%20RL,%20Rath%20TJ,%20Assaad%20AM,%20Chiosea%20SI.%20Human%20papillomavirus%20and%20Epstein-Barr%20virus%20in%20nasopharyngeal%20carcinoma%20in%20a%20low-incidence%20population.%20Head%20Neck.%202014;36:511%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Stenmark MH, McHugh JB, Schipper M, et al. Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis. Int J Radiat Oncol Biol Phys. 2014;88:580–8.
</cite> [<a href="https://doi.org/10.1016/j.ijrobp.2013.11.246" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3989890/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24521676/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Stenmark%20MH,%20McHugh%20JB,%20Schipper%20M,%20et%20al.%20Nonendemic%20HPV-positive%20nasopharyngeal%20carcinoma:%20association%20with%20poor%20prognosis.%20Int%20J%20Radiat%20Oncol%20Biol%20Phys.%202014;88:580%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Wan X, Liu Y, Peng Y, et al. Primary and orthotopic murine models of nasopharyngeal carcinoma reveal molecular mechanisms underlying its malignant progression. Adv Sci (Weinh). 2024;11(36):e2403161.</cite> [<a href="https://doi.org/10.1002/advs.202403161" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11423139/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39049720/" class="usa-link">PubMed</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Lv J, Xu LX, Li ZX et al. Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: The EP-SEASON study. Cancer Cell. 2024;42:1401-14.e1404.</cite> [<a href="https://doi.org/10.1016/j.ccell.2024.07.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39059389/" class="usa-link">PubMed</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Wang Q, Xie H, Li Y, et al. Racial and ethnic disparities in nasopharyngeal cancer with an emphasis among Asian Americans. Int J Cancer. 2022;151(8):1291–303.
</cite> [<a href="https://doi.org/10.1002/ijc.34154" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35666524/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Q,%20Xie%20H,%20Li%20Y,%20et%20al.%20Racial%20and%20ethnic%20disparities%20in%20nasopharyngeal%20cancer%20with%20an%20emphasis%20among%20Asian%20Americans.%20Int%20J%20Cancer.%202022;151(8):1291%E2%80%93303." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Guo LF, Hong JG, Wang RJ, et al. Nasopharyngeal carcinoma survival by histology in endemic and non-endemic areas. Ann Med. 2024;56(1): 2425066.
</cite> [<a href="https://doi.org/10.1080/07853890.2024.2425066" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11559018/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39529559/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guo%20LF,%20Hong%20JG,%20Wang%20RJ,%20et%20al.%20Nasopharyngeal%20carcinoma%20survival%20by%20histology%20in%20endemic%20and%20non-endemic%20areas.%20Ann%20Med.%202024;56(1):%202425066." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Ruuskanen M, Irjala H, Minn H, et al. Epstein-Barr virus and human papillomaviruses as favorable prognostic factors in nasopharyngeal carcinoma: a nationwide study in Finland. Head Neck. 2019;41:349–57.
</cite> [<a href="https://doi.org/10.1002/hed.25450" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6590344/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30549170/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ruuskanen%20M,%20Irjala%20H,%20Minn%20H,%20et%20al.%20Epstein-Barr%20virus%20and%20human%20papillomaviruses%20as%20favorable%20prognostic%20factors%20in%20nasopharyngeal%20carcinoma:%20a%20nationwide%20study%20in%20Finland.%20Head%20Neck.%202019;41:349%E2%80%9357." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Bossi P, Trama A, Bernasconi A, et al. Nasopharyngeal cancer in non-endemic areas: impact of treatment intensity within a large retrospective multicentre cohort. Eur J Cancer. 2021;159:194–204.
</cite> [<a href="https://doi.org/10.1016/j.ejca.2021.09.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34773903/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bossi%20P,%20Trama%20A,%20Bernasconi%20A,%20et%20al.%20Nasopharyngeal%20cancer%20in%20non-endemic%20areas:%20impact%20of%20treatment%20intensity%20within%20a%20large%20retrospective%20multicentre%20cohort.%20Eur%20J%20Cancer.%202021;159:194%E2%80%93204." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Neo J, Yip PL, Ong EHW, et al. Longitudinal post-radiotherapy plasma Epstein-Barr virus DNA trends inform on optimal risk stratification in endemic nasopharyngeal carcinoma. Oral Oncol. 2024;148: 106655.
</cite> [<a href="https://doi.org/10.1016/j.oraloncology.2023.106655" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38056062/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Neo%20J,%20Yip%20PL,%20Ong%20EHW,%20et%20al.%20Longitudinal%20post-radiotherapy%20plasma%20Epstein-Barr%20virus%20DNA%20trends%20inform%20on%20optimal%20risk%20stratification%20in%20endemic%20nasopharyngeal%20carcinoma.%20Oral%20Oncol.%202024;148:%20106655." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Li W, Chen J, Liang B, et al. Long-term monitoring of dynamic changes in plasma EBV DNA for improved prognosis prediction of nasopharyngeal carcinoma. Cancer Med. 2021;10:883–94.
</cite> [<a href="https://doi.org/10.1002/cam4.3669" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7897970/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33378109/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20W,%20Chen%20J,%20Liang%20B,%20et%20al.%20Long-term%20monitoring%20of%20dynamic%20changes%20in%20plasma%20EBV%20DNA%20for%20improved%20prognosis%20prediction%20of%20nasopharyngeal%20carcinoma.%20Cancer%20Med.%202021;10:883%E2%80%9394." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Nicholls JM, Lee VH, Chan SK, et al. Negative plasma Epstein-barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes. Br J Cancer. 2019;121:690–8.
</cite> [<a href="https://doi.org/10.1038/s41416-019-0575-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6888810/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31527689/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nicholls%20JM,%20Lee%20VH,%20Chan%20SK,%20et%20al.%20Negative%20plasma%20Epstein-barr%20virus%20DNA%20nasopharyngeal%20carcinoma%20in%20an%20endemic%20region%20and%20its%20influence%20on%20liquid%20biopsy%20screening%20programmes.%20Br%20J%20Cancer.%202019;121:690%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Kim KY, Le QT, Yom SS, et al. Clinical utility of epstein-barr virus DNA testing in the treatment of nasopharyngeal carcinoma patients. Int J Radiat Oncol Biol Phys. 2017;98:996–1001.
</cite> [<a href="https://doi.org/10.1016/j.ijrobp.2017.03.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28721913/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20KY,%20Le%20QT,%20Yom%20SS,%20et%20al.%20Clinical%20utility%20of%20epstein-barr%20virus%20DNA%20testing%20in%20the%20treatment%20of%20nasopharyngeal%20carcinoma%20patients.%20Int%20J%20Radiat%20Oncol%20Biol%20Phys.%202017;98:996%E2%80%931001." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Le QT, Yom SS, Ng RHW, et al. In reply to Zoto Mustafayev and Ozyar. Int J Radiat Oncol Biol Phys. 2017;99:1307.</cite> [<a href="https://doi.org/10.1016/j.ijrobp.2017.08.036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29165290/" class="usa-link">PubMed</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Yang S, Zhao K, Ding X, et al. Prognostic significance of hematological markers for patients with nasopharyngeal carcinoma: a meta-analysis. J Cancer. 2019;10:2568–77.
</cite> [<a href="https://doi.org/10.7150/jca.26770" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6584332/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31258763/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20S,%20Zhao%20K,%20Ding%20X,%20et%20al.%20Prognostic%20significance%20of%20hematological%20markers%20for%20patients%20with%20nasopharyngeal%20carcinoma:%20a%20meta-analysis.%20J%20Cancer.%202019;10:2568%E2%80%9377." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Kanakry JA, Hegde AM, Durand CM, et al. The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases. Blood. 2016;127(16):2007–17.
</cite> [<a href="https://doi.org/10.1182/blood-2015-09-672030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4841041/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26744460/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kanakry%20JA,%20Hegde%20AM,%20Durand%20CM,%20et%20al.%20The%20clinical%20significance%20of%20EBV%20DNA%20in%20the%20plasma%20and%20peripheral%20blood%20mononuclear%20cells%20of%20patients%20with%20or%20without%20EBV%20diseases.%20Blood.%202016;127(16):2007%E2%80%9317." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Nagahara T, Sugihara T, Kihara T, et al. The characteristics and prognosis of Alpha-fetoprotein and Des-gamma-carboxy prothrombin double-negative hepatocellular carcinoma at baseline in higher BCLC stages. Cancers. 2023;15:390.
</cite> [<a href="https://doi.org/10.3390/cancers15020390" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9856355/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36672339/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nagahara%20T,%20Sugihara%20T,%20Kihara%20T,%20et%20al.%20The%20characteristics%20and%20prognosis%20of%20Alpha-fetoprotein%20and%20Des-gamma-carboxy%20prothrombin%20double-negative%20hepatocellular%20carcinoma%20at%20baseline%20in%20higher%20BCLC%20stages.%20Cancers.%202023;15:390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12374416/bin/12903_2025_6733_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1.</a><sup> (124.6KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Data of this study would not be shared. If necessary, data could be obtained from the corresponding authors.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from BMC Oral Health are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s12903-025-06733-5"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/12903_2025_Article_6733.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (5.5 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12374416/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12374416/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12374416%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12374416/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12374416/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12374416/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40849665/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12374416/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40849665/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12374416/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12374416/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="5KedeM6yjUG7DqvqazmOjF3rIhsOBZ0FGi3E7jTsaCUBIcL6avuhhUtigW2XBvOi">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
